Inactive Instrument

Analyst Reco. DFB Healthcare Acquisitions Corp. Nasdaq

Equities

US23291E2081

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

UBS Adjusts AdaptHealth Price Target to $13 From $9, Maintains Buy Rating	02-28	MT
Deutsche Bank Adjusts AdaptHealth Price Target to $10 From $8, Maintains Hold Rating	02-28	MT
UBS Trims AdaptHealth Price Target to $9 From $10, Maintains Buy Rating	01-29	MT
UBS Adjusts AdaptHealth Price Target to $10 From $18, Maintains Buy Rating	11-08	MT
BofA Securities Downgrades AdaptHealth to Underperform From Neutral, Adjusts Price Target to $6.50 From $9.50	11-08	MT
Deutsche Bank Adjusts AdaptHealth Price Target to $8 From $14, Maintains Hold Rating	11-08	MT
RBC Cuts Price Target on AdaptHealth to $13 From $18, Keeps Outperform Rating	11-08	MT
BofA Securities Adjusts AdaptHealth's Price Target to $11 From $13, Keeps Neutral Rating	23-09-22	MT
Deutsche Bank Raises AdaptHealth Price Target to $14 From $11.30, Maintains Hold Rating	23-08-14	MT
UBS Adjusts AdaptHealth Price Target to $18 From $15, Maintains Buy Rating	23-08-09	MT
Baird Adjusts Price Target on AdaptHealth to $21 From $20, Maintains Outperform Rating	23-07-13	MT
RBC Cuts Price Target on AdaptHealth to $18 From $24 After Q1 Miss, Notes Unexpected Weakness in Diabetes, Keeps Outperform Rating	23-05-11	MT
Deutsche Bank Downgrades AdaptHealth to Hold From Buy, Adjusts Price Target to $11.30 From $28	23-05-10	MT
Canaccord Genuity Adjusts AdaptHealth's Price Target to $17 From $22, Keeps Buy Rating	23-05-10	MT
Baird Adjusts Price Target on AdaptHealth to $20 From $23, Maintains Outperform Rating	23-05-10	MT
UBS Adjusts AdaptHealth Price Target to $15 From $18, Maintains Buy Rating	23-05-10	MT
Stifel Downgrades AdaptHealth to Hold From Buy, Adjusts Price Target to $11 From $18	23-05-10	MT
Truist Securities Adjusts Price Target on AdaptHealth to $17 From $20, Maintains Buy Rating	23-04-13	MT
UBS Adjusts AdaptHealth Price Target to $18 From $25, Maintains Buy Rating	23-03-14	MT
Baird Adjusts Price Target on AdaptHealth to $23 From $31, Maintains Outperform Rating	23-03-01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. DFB Healthcare Acquisitions Corp. Nasdaq

Equities

US23291E2081

Analyst Reco.

Filters